Urogen Pharma Competitors and Similar CompaniesClear all

ESSA Pharma's competitors and similar companies include LadRx, Fennec Pharma and Rasna Therapeutics.
ESSA Pharma
ESSA Pharma
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
LadRx
LadRx
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
Fennec Pharma
Fennec Pharma
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
Rasna Therapeutics
Rasna Therapeutics
Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
Founding Date
Founding Date
2009
Founding Date
1985
Founding Date
1996
Founding Date
2013
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Vancouver, CA HQ
Houston, US
South San Francisco, US
Locations
Los Angeles, US HQ
Locations
US HQ
Locations
New York, US HQ
Greater London, GB
Doylestown, US
Employees
Employees
35
Employees
385% decrease
Employees
433% increase
Employees
N/A
Valuation ($)
Valuation ($)
240 m
Valuation ($)
901.1 k
Valuation ($)
129.4 m
Valuation ($)
3.1 m

Financial

Net income
Net income
($28.5m) (FY, 2024)
Net income
($1.6m) (FY, 2024)
Net income
($9.7m) (FY, 2025)
Net income
($4.4m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 74.1m
Total funding raised
N/A
Total funding raised
$ 2.2m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

LadRx
HQ
Los Angeles, US
Employees
3

LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.

View company
Fennec Pharma
HQ
US
Employees
4↑ 33% increase

Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.

View company
Rasna Therapeutics
HQ
New York, US

Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.

View company